| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |